Compare Flux Power Holdings Inc (FLUX) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Flux Power Holdings Inc vs TransMedics Group Inc — how do they compare? Flux Power Holdings Inc trades at $0.48 (market cap $9.97M), while TransMedics Group Inc trades at $77.87 (market cap $2.74B). The key difference: TransMedics Group Inc is far larger — about 274.8× Flux Power Holdings Inc's market cap, and TransMedics Group Inc is trading nearer its 52-week high, Flux Power Holdings Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Flux Power Holdings Inc for 20 Days and TransMedics Group Inc for 24 Days on average.
| FLUX | TMDX | |
|---|---|---|
Market Cap | $9.97M | $2.74B |
Volume | 817,320 | 949,331 |
Sector | Industrials | Health |
52-Week High | $6.66 | $150.42 |
52-Week Low | $0.41 | $61.99 |
Typical Hold Time | 20 Days | 24 Days |
Enterprise Value | $18.18M | $3.13B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLUX trades at $0.47, down 3.96% today, with bearish technical signals from moving averages. The company reported Q4 2026 revenue of $8.2M, beating expectations, but posted a net loss of $6.67M for 2025. Recent news highlights a rejected acquisition proposal from Solidion Technology. Despite negative profitability metrics, all six covering analysts maintain Buy ratings.
FLUX faces significant execution risks with negative margins and cash flow challenges, but analyst consensus remains bullish. The stock's current valuation at 0.22 P/S suggests potential upside if operational improvements materialize. Key risks include sustained losses and competitive pressures in the energy storage sector.
TransMedics Group (TMDX) trades at $77.87, down 3.95% on the day, amid a bearish technical signal and recent earnings misses. The company maintains strong profitability with a 22.69% net income margin and 36.28% ROE, though 2026 projections show margin compression. Analyst consensus remains bullish with a $99.75 price target, but sentiment is clouded by multiple legal investigations into fiduciary duties announced in late August and September 2026.
The stock faces near-term pressure from technical weakness and legal overhangs, but solid fundamentals and analyst conviction suggest long-term potential if execution improves. Key risks include ongoing legal scrutiny, margin pressures from heavy investment, and volatility around future earnings reports.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Flux Power Holdings Inc
Flux Power designs and manufactures lithium-ion battery packs for industrial vehicles. Its sustainable energy solutions power material handling equipment like forklifts and airport ground support vehicles.
Read more on FLUX →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
